|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM098558455 |
003 |
DE-627 |
005 |
20250201004654.0 |
007 |
tu |
008 |
231222s1998 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed25n0329.xml
|
035 |
|
|
|a (DE-627)NLM098558455
|
035 |
|
|
|a (NLM)9920680
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Lancashire, C
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Apolipoprotein E antibodies affect the retention of passive avoidance memory in the chick
|
264 |
|
1 |
|c 1998
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 13.04.1999
|
500 |
|
|
|a Date Revised 16.03.2016
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Isoforms of apolipoprotein E (ApoE) have been implicated as risk factors in Alzheimer's disease. We have, therefore, examined the possible role of ApoE in memory formation, using a one-trial passive avoidance task in day-old chicks. Birds were trained on the task and then at various times pre or post-training were injected intracerebrally with anti-ApoE. Immunofluorescence staining demonstrated the presence of the antibody bound to the neuropil, close to the injection site and adjacent to the ventricle, with a residence time in the brain of up to 30 min. Chicks that were injected 30 min pre-training or just post-training with 5 micrograms/hemisphere of the antibody learned the task, but were amnesic when tested at 30 min or at subsequent times up to 24 hr post-training. When tested at 24 hr, birds injected 5.5 hr post-training showed unimpaired retention. Birds injected with 5 micrograms/hemisphere of anti-ApoA-I (which has a brain distribution similar to that of anti-ApoE) at 30 min pretraining showed no amnesia, indicating the specificity of the effect to the ApoE. Possible mechanisms for this effect are discussed
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Antibodies
|2 NLM
|
650 |
|
7 |
|a Apolipoprotein A-I
|2 NLM
|
650 |
|
7 |
|a Apolipoproteins E
|2 NLM
|
700 |
1 |
|
|a Mileusnic, R
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Rose, S P
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Neural plasticity
|d 1998
|g 6(1998), 3 vom: 01. Juli, Seite 29-40
|w (DE-627)NLM098558390
|x 2090-5904
|7 nnns
|
773 |
1 |
8 |
|g volume:6
|g year:1998
|g number:3
|g day:01
|g month:07
|g pages:29-40
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_21
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 6
|j 1998
|e 3
|b 01
|c 07
|h 29-40
|